nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—obesity	0.283	1	CbGaD
Nepafenac—Tiaprofenic acid—Diethylpropion—obesity	0.22	0.399	CrCrCtD
Nepafenac—Phenacemide—Phentermine—obesity	0.117	0.212	CrCrCtD
Nepafenac—Phenacemide—Methamphetamine—obesity	0.104	0.189	CrCrCtD
Nepafenac—Modafinil—Benzphetamine—obesity	0.0653	0.118	CrCrCtD
Nepafenac—Benzyl Benzoate—Benzphetamine—obesity	0.0455	0.0823	CrCrCtD
Nepafenac—Lacrimation decreased—Bupropion—obesity	0.00527	0.0575	CcSEcCtD
Nepafenac—PTGS2—ovarian follicle—obesity	0.00456	0.351	CbGeAlD
Nepafenac—Rheumatoid arthritis—Sibutramine—obesity	0.00328	0.0359	CcSEcCtD
Nepafenac—Blood pressure increased—Phendimetrazine—obesity	0.00274	0.03	CcSEcCtD
Nepafenac—Iritis—Sibutramine—obesity	0.00261	0.0285	CcSEcCtD
Nepafenac—Blood pressure increased—Phenylpropanolamine—obesity	0.00234	0.0256	CcSEcCtD
Nepafenac—Intraocular pressure increased—Sibutramine—obesity	0.00226	0.0246	CcSEcCtD
Nepafenac—Impaired healing—Bupropion—obesity	0.002	0.0218	CcSEcCtD
Nepafenac—Conjunctival oedema—Topiramate—obesity	0.00198	0.0217	CcSEcCtD
Nepafenac—Intraocular pressure increased—Bupropion—obesity	0.00197	0.0215	CcSEcCtD
Nepafenac—Blood pressure increased—Diethylpropion—obesity	0.00195	0.0213	CcSEcCtD
Nepafenac—Pregnancy—Bupropion—obesity	0.00152	0.0166	CcSEcCtD
Nepafenac—Iritis—Topiramate—obesity	0.00145	0.0158	CcSEcCtD
Nepafenac—Intraocular pressure increased—Topiramate—obesity	0.00125	0.0137	CcSEcCtD
Nepafenac—Ocular hyperaemia—Topiramate—obesity	0.00117	0.0128	CcSEcCtD
Nepafenac—Dermatitis atopic—Bupropion—obesity	0.00117	0.0128	CcSEcCtD
Nepafenac—Endophthalmitis—Topiramate—obesity	0.00116	0.0126	CcSEcCtD
Nepafenac—Vision blurred—Phendimetrazine—obesity	0.00113	0.0123	CcSEcCtD
Nepafenac—Cataract—Sibutramine—obesity	0.00104	0.0114	CcSEcCtD
Nepafenac—Blood pressure increased—Sibutramine—obesity	0.000992	0.0108	CcSEcCtD
Nepafenac—PTGS2—gall bladder—obesity	0.000973	0.0749	CbGeAlD
Nepafenac—Vision blurred—Phenylpropanolamine—obesity	0.000966	0.0105	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Methamphetamine—obesity	0.000962	0.0105	CcSEcCtD
Nepafenac—Lacrimation increased—Bupropion—obesity	0.000938	0.0102	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Benzphetamine—obesity	0.000927	0.0101	CcSEcCtD
Nepafenac—Visual acuity reduced—Topiramate—obesity	0.000926	0.0101	CcSEcCtD
Nepafenac—Dry eye—Sibutramine—obesity	0.000916	0.01	CcSEcCtD
Nepafenac—Blood pressure increased—Bupropion—obesity	0.000865	0.00945	CcSEcCtD
Nepafenac—Diabetes mellitus—Orlistat—obesity	0.000855	0.00934	CcSEcCtD
Nepafenac—Hypertension—Phentermine—obesity	0.000847	0.00925	CcSEcCtD
Nepafenac—Diabetes mellitus—Sibutramine—obesity	0.000828	0.00904	CcSEcCtD
Nepafenac—Hypersensitivity—Methamphetamine—obesity	0.000821	0.00896	CcSEcCtD
Nepafenac—Dry mouth—Phentermine—obesity	0.000816	0.00892	CcSEcCtD
Nepafenac—Photophobia—Bupropion—obesity	0.000812	0.00887	CcSEcCtD
Nepafenac—Vision blurred—Diethylpropion—obesity	0.000804	0.00878	CcSEcCtD
Nepafenac—Dry eye—Bupropion—obesity	0.000799	0.00872	CcSEcCtD
Nepafenac—Eye pain—Sibutramine—obesity	0.000798	0.00871	CcSEcCtD
Nepafenac—Hypersensitivity—Benzphetamine—obesity	0.000791	0.00864	CcSEcCtD
Nepafenac—Mefenamic acid—AKR1C3—obesity	0.00077	0.232	CrCbGaD
Nepafenac—Arthritis—Orlistat—obesity	0.000766	0.00836	CcSEcCtD
Nepafenac—Dermatitis atopic—Topiramate—obesity	0.000744	0.00813	CcSEcCtD
Nepafenac—Arthritis—Sibutramine—obesity	0.000741	0.00809	CcSEcCtD
Nepafenac—Dizziness—Methamphetamine—obesity	0.000737	0.00804	CcSEcCtD
Nepafenac—Dizziness—Benzphetamine—obesity	0.00071	0.00776	CcSEcCtD
Nepafenac—Dry mouth—Diethylpropion—obesity	0.00071	0.00776	CcSEcCtD
Nepafenac—Headache—Methamphetamine—obesity	0.000698	0.00762	CcSEcCtD
Nepafenac—Eye pain—Bupropion—obesity	0.000695	0.00759	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Phentermine—obesity	0.000691	0.00755	CcSEcCtD
Nepafenac—Headache—Benzphetamine—obesity	0.000673	0.00735	CcSEcCtD
Nepafenac—Dizziness—Phendimetrazine—obesity	0.000647	0.00707	CcSEcCtD
Nepafenac—Arthritis—Bupropion—obesity	0.000646	0.00705	CcSEcCtD
Nepafenac—Nausea—Benzphetamine—obesity	0.000638	0.00697	CcSEcCtD
Nepafenac—PTGS2—islet of Langerhans—obesity	0.000638	0.0491	CbGeAlD
Nepafenac—PTGS1—respiratory system—obesity	0.00063	0.0485	CbGeAlD
Nepafenac—Hypersensitivity—Phenylpropanolamine—obesity	0.000616	0.00673	CcSEcCtD
Nepafenac—Headache—Phendimetrazine—obesity	0.000613	0.0067	CcSEcCtD
Nepafenac—PTGS2—respiratory system—obesity	0.000602	0.0464	CbGeAlD
Nepafenac—Gastrointestinal disorder—Diethylpropion—obesity	0.000601	0.00656	CcSEcCtD
Nepafenac—Lacrimation increased—Topiramate—obesity	0.000598	0.00653	CcSEcCtD
Nepafenac—Nausea—Phendimetrazine—obesity	0.000581	0.00635	CcSEcCtD
Nepafenac—Dizziness—Phenylpropanolamine—obesity	0.000553	0.00604	CcSEcCtD
Nepafenac—Sinusitis—Orlistat—obesity	0.000538	0.00588	CcSEcCtD
Nepafenac—Vomiting—Phenylpropanolamine—obesity	0.000532	0.00581	CcSEcCtD
Nepafenac—Dizziness—Phentermine—obesity	0.000529	0.00578	CcSEcCtD
Nepafenac—Sinusitis—Sibutramine—obesity	0.000521	0.00569	CcSEcCtD
Nepafenac—Photophobia—Topiramate—obesity	0.000517	0.00565	CcSEcCtD
Nepafenac—Dry eye—Topiramate—obesity	0.000509	0.00556	CcSEcCtD
Nepafenac—Vomiting—Phentermine—obesity	0.000509	0.00556	CcSEcCtD
Nepafenac—PTGS2—adrenal cortex—obesity	0.000505	0.0389	CbGeAlD
Nepafenac—Headache—Phentermine—obesity	0.000501	0.00548	CcSEcCtD
Nepafenac—Nausea—Phenylpropanolamine—obesity	0.000497	0.00543	CcSEcCtD
Nepafenac—Hypersensitivity—Cimetidine—obesity	0.000488	0.00533	CcSEcCtD
Nepafenac—PTGS1—cardiovascular system—obesity	0.000483	0.0372	CbGeAlD
Nepafenac—Nausea—Phentermine—obesity	0.000475	0.00519	CcSEcCtD
Nepafenac—Eye disorder—Sibutramine—obesity	0.000466	0.00508	CcSEcCtD
Nepafenac—Immune system disorder—Orlistat—obesity	0.000465	0.00508	CcSEcCtD
Nepafenac—PTGS2—cardiovascular system—obesity	0.000461	0.0355	CbGeAlD
Nepafenac—Dizziness—Diethylpropion—obesity	0.00046	0.00503	CcSEcCtD
Nepafenac—Diabetes mellitus—Topiramate—obesity	0.00046	0.00502	CcSEcCtD
Nepafenac—Sinusitis—Bupropion—obesity	0.000454	0.00496	CcSEcCtD
Nepafenac—Angiopathy—Sibutramine—obesity	0.000452	0.00494	CcSEcCtD
Nepafenac—Immune system disorder—Sibutramine—obesity	0.00045	0.00491	CcSEcCtD
Nepafenac—Eye pain—Topiramate—obesity	0.000443	0.00484	CcSEcCtD
Nepafenac—Vomiting—Diethylpropion—obesity	0.000443	0.00483	CcSEcCtD
Nepafenac—Dizziness—Cimetidine—obesity	0.000438	0.00478	CcSEcCtD
Nepafenac—Headache—Diethylpropion—obesity	0.000436	0.00476	CcSEcCtD
Nepafenac—PTGS1—pituitary gland—obesity	0.000427	0.0329	CbGeAlD
Nepafenac—PTGS1—adipose tissue—obesity	0.000426	0.0328	CbGeAlD
Nepafenac—Vision blurred—Orlistat—obesity	0.000422	0.00461	CcSEcCtD
Nepafenac—Vomiting—Cimetidine—obesity	0.000421	0.0046	CcSEcCtD
Nepafenac—Headache—Cimetidine—obesity	0.000415	0.00453	CcSEcCtD
Nepafenac—Nausea—Diethylpropion—obesity	0.000413	0.00452	CcSEcCtD
Nepafenac—Vision blurred—Sibutramine—obesity	0.000409	0.00446	CcSEcCtD
Nepafenac—PTGS2—pituitary gland—obesity	0.000408	0.0315	CbGeAlD
Nepafenac—PTGS2—adipose tissue—obesity	0.000407	0.0313	CbGeAlD
Nepafenac—Eye disorder—Bupropion—obesity	0.000406	0.00443	CcSEcCtD
Nepafenac—PTGS1—digestive system—obesity	0.000401	0.0308	CbGeAlD
Nepafenac—Angiopathy—Bupropion—obesity	0.000394	0.0043	CcSEcCtD
Nepafenac—Nausea—Cimetidine—obesity	0.000393	0.0043	CcSEcCtD
Nepafenac—Immune system disorder—Bupropion—obesity	0.000392	0.00428	CcSEcCtD
Nepafenac—PTGS2—digestive system—obesity	0.000383	0.0295	CbGeAlD
Nepafenac—PTGS1—adrenal gland—obesity	0.000382	0.0294	CbGeAlD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000379	0.00414	CcSEcCtD
Nepafenac—Hypertension—Sibutramine—obesity	0.000374	0.00409	CcSEcCtD
Nepafenac—Dry mouth—Orlistat—obesity	0.000373	0.00407	CcSEcCtD
Nepafenac—PTGS2—adrenal gland—obesity	0.000365	0.0281	CbGeAlD
Nepafenac—Dry mouth—Sibutramine—obesity	0.000361	0.00394	CcSEcCtD
Nepafenac—Nervous system disorder—Orlistat—obesity	0.000359	0.00392	CcSEcCtD
Nepafenac—Vision blurred—Bupropion—obesity	0.000356	0.00389	CcSEcCtD
Nepafenac—Skin disorder—Orlistat—obesity	0.000355	0.00388	CcSEcCtD
Nepafenac—Skin disorder—Sibutramine—obesity	0.000344	0.00375	CcSEcCtD
Nepafenac—PTGS1—endocrine gland—obesity	0.000331	0.0255	CbGeAlD
Nepafenac—Hypertension—Bupropion—obesity	0.000326	0.00356	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00032	0.00349	CcSEcCtD
Nepafenac—PTGS2—endocrine gland—obesity	0.000316	0.0244	CbGeAlD
Nepafenac—Gastrointestinal disorder—Orlistat—obesity	0.000316	0.00345	CcSEcCtD
Nepafenac—Dry mouth—Bupropion—obesity	0.000315	0.00344	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Sibutramine—obesity	0.000306	0.00334	CcSEcCtD
Nepafenac—Nervous system disorder—Bupropion—obesity	0.000303	0.0033	CcSEcCtD
Nepafenac—Skin disorder—Bupropion—obesity	0.0003	0.00327	CcSEcCtD
Nepafenac—Sinusitis—Topiramate—obesity	0.000289	0.00316	CcSEcCtD
Nepafenac—PTGS2—liver—obesity	0.000285	0.022	CbGeAlD
Nepafenac—Ketorolac—PTGS2—obesity	0.000273	0.0823	CrCbGaD
Nepafenac—Hypersensitivity—Orlistat—obesity	0.000269	0.00294	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Bupropion—obesity	0.000266	0.00291	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—obesity	0.000262	0.0789	CrCbGaD
Nepafenac—Hypersensitivity—Sibutramine—obesity	0.000261	0.00285	CcSEcCtD
Nepafenac—Pruritus—Orlistat—obesity	0.000259	0.00283	CcSEcCtD
Nepafenac—Eye disorder—Topiramate—obesity	0.000259	0.00282	CcSEcCtD
Nepafenac—Angiopathy—Topiramate—obesity	0.000251	0.00274	CcSEcCtD
Nepafenac—Pruritus—Sibutramine—obesity	0.00025	0.00273	CcSEcCtD
Nepafenac—Immune system disorder—Topiramate—obesity	0.00025	0.00273	CcSEcCtD
Nepafenac—Dizziness—Orlistat—obesity	0.000242	0.00264	CcSEcCtD
Nepafenac—Dizziness—Sibutramine—obesity	0.000234	0.00256	CcSEcCtD
Nepafenac—Vomiting—Orlistat—obesity	0.000233	0.00254	CcSEcCtD
Nepafenac—Headache—Orlistat—obesity	0.000229	0.0025	CcSEcCtD
Nepafenac—Hypersensitivity—Bupropion—obesity	0.000227	0.00248	CcSEcCtD
Nepafenac—Vision blurred—Topiramate—obesity	0.000227	0.00248	CcSEcCtD
Nepafenac—Vomiting—Sibutramine—obesity	0.000225	0.00246	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—obesity	0.000223	0.0671	CrCbGaD
Nepafenac—Headache—Sibutramine—obesity	0.000222	0.00242	CcSEcCtD
Nepafenac—Pruritus—Bupropion—obesity	0.000218	0.00238	CcSEcCtD
Nepafenac—Nausea—Orlistat—obesity	0.000217	0.00237	CcSEcCtD
Nepafenac—Nausea—Sibutramine—obesity	0.00021	0.0023	CcSEcCtD
Nepafenac—Hypertension—Topiramate—obesity	0.000208	0.00227	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—obesity	0.000207	0.0624	CrCbGaD
Nepafenac—Dizziness—Bupropion—obesity	0.000204	0.00223	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000204	0.00222	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—obesity	0.000203	0.061	CrCbGaD
Nepafenac—Dry mouth—Topiramate—obesity	0.000201	0.00219	CcSEcCtD
Nepafenac—Vomiting—Bupropion—obesity	0.000196	0.00214	CcSEcCtD
Nepafenac—Headache—Bupropion—obesity	0.000193	0.00211	CcSEcCtD
Nepafenac—Nervous system disorder—Topiramate—obesity	0.000193	0.00211	CcSEcCtD
Nepafenac—Skin disorder—Topiramate—obesity	0.000191	0.00209	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—obesity	0.000184	0.0556	CrCbGaD
Nepafenac—Nausea—Bupropion—obesity	0.000183	0.002	CcSEcCtD
Nepafenac—Salsalate—PTGS2—obesity	0.000176	0.053	CrCbGaD
Nepafenac—Gastrointestinal disorder—Topiramate—obesity	0.00017	0.00185	CcSEcCtD
Nepafenac—Diclofenac—CYP2E1—obesity	0.000157	0.0474	CrCbGaD
Nepafenac—Fenoprofen—PTGS2—obesity	0.000145	0.0438	CrCbGaD
Nepafenac—Hypersensitivity—Topiramate—obesity	0.000145	0.00158	CcSEcCtD
Nepafenac—Pruritus—Topiramate—obesity	0.000139	0.00152	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS2—obesity	0.000135	0.0406	CrCbGaD
Nepafenac—Dizziness—Topiramate—obesity	0.00013	0.00142	CcSEcCtD
Nepafenac—Fenoprofen—ALB—obesity	0.00013	0.039	CrCbGaD
Nepafenac—Vomiting—Topiramate—obesity	0.000125	0.00137	CcSEcCtD
Nepafenac—Headache—Topiramate—obesity	0.000123	0.00135	CcSEcCtD
Nepafenac—Nausea—Topiramate—obesity	0.000117	0.00128	CcSEcCtD
Nepafenac—Oxcarbazepine—ALB—obesity	0.000109	0.0328	CrCbGaD
Nepafenac—Diclofenac—PTGS2—obesity	9.69e-05	0.0292	CrCbGaD
Nepafenac—Diclofenac—ALB—obesity	8.64e-05	0.026	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—obesity	8.59e-05	0.0259	CrCbGaD
Nepafenac—Ketoprofen—ALB—obesity	7.65e-05	0.023	CrCbGaD
Nepafenac—PTGS2—Metabolism—OXCT1—obesity	3.3e-05	0.000587	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYTB—obesity	3.3e-05	0.000587	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACACB—obesity	3.3e-05	0.000587	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PCK1—obesity	3.24e-05	0.000576	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HADH—obesity	3.24e-05	0.000576	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FADS1—obesity	3.24e-05	0.000576	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PNLIP—obesity	3.22e-05	0.000572	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SRD5A1—obesity	3.22e-05	0.000572	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPL—obesity	3.19e-05	0.000567	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ACP5—obesity	3.16e-05	0.00056	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SDC3—obesity	3.14e-05	0.000558	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GGT1—obesity	3.13e-05	0.000555	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—obesity	3.12e-05	0.000553	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—obesity	3.08e-05	0.000547	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—G6PD—obesity	3.07e-05	0.000546	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PCK1—obesity	3.07e-05	0.000546	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HK2—obesity	3.07e-05	0.000546	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—STS—obesity	3.07e-05	0.000546	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP26B1—obesity	3.07e-05	0.000546	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HK1—obesity	3.04e-05	0.000539	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SREBF2—obesity	3.04e-05	0.000539	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—obesity	3.04e-05	0.000539	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CD36—obesity	3.03e-05	0.000539	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARD—obesity	3.01e-05	0.000534	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ACP5—obesity	2.99e-05	0.000531	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	2.97e-05	0.000528	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC27A1—obesity	2.95e-05	0.000523	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPA—obesity	2.93e-05	0.000521	CbGpPWpGaD
Nepafenac—PTGS2—Disease—G6PD—obesity	2.91e-05	0.000517	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FABP4—obesity	2.89e-05	0.000513	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GLUL—obesity	2.89e-05	0.000513	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HK1—obesity	2.88e-05	0.000511	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPIN1—obesity	2.87e-05	0.00051	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—obesity	2.82e-05	0.000501	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA5—obesity	2.81e-05	0.000499	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—obesity	2.79e-05	0.000496	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	2.78e-05	0.000494	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UCP2—obesity	2.74e-05	0.000486	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UCP3—obesity	2.74e-05	0.000486	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ECHS1—obesity	2.74e-05	0.000486	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSD11B1—obesity	2.74e-05	0.000486	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AGT—obesity	2.73e-05	0.000485	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADH1B—obesity	2.69e-05	0.000478	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CLOCK—obesity	2.68e-05	0.000476	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC22A1—obesity	2.68e-05	0.000476	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—obesity	2.68e-05	0.000475	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOB—obesity	2.65e-05	0.000471	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARGC1B—obesity	2.65e-05	0.000471	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACSL1—obesity	2.65e-05	0.000471	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPAM—obesity	2.65e-05	0.000471	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—obesity	2.65e-05	0.000471	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA1—obesity	2.65e-05	0.00047	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GLP1R—obesity	2.61e-05	0.000464	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SULT2A1—obesity	2.61e-05	0.000464	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HADH—obesity	2.57e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PCK1—obesity	2.57e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FADS1—obesity	2.57e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DPYD—obesity	2.57e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPL—obesity	2.53e-05	0.00045	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—obesity	2.53e-05	0.000449	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	2.52e-05	0.000448	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACP5—obesity	2.5e-05	0.000445	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RBP4—obesity	2.48e-05	0.00044	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PRKAR2B—obesity	2.48e-05	0.00044	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—obesity	2.47e-05	0.000439	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DCN—obesity	2.46e-05	0.000436	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—G6PD—obesity	2.44e-05	0.000433	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2.42e-05	0.000429	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SREBF2—obesity	2.41e-05	0.000428	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HK1—obesity	2.41e-05	0.000428	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CD36—obesity	2.41e-05	0.000428	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CPT1A—obesity	2.39e-05	0.000425	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—obesity	2.35e-05	0.000418	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CST3—obesity	2.35e-05	0.000417	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRKAR2B—obesity	2.35e-05	0.000417	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NAMPT—obesity	2.34e-05	0.000416	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—obesity	2.33e-05	0.000414	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LIPC—obesity	2.33e-05	0.000414	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCK—obesity	2.33e-05	0.000414	CbGpPWpGaD
Nepafenac—PTGS2—Disease—DCN—obesity	2.33e-05	0.000414	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPA—obesity	2.33e-05	0.000413	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOC3—obesity	2.32e-05	0.000411	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—obesity	2.3e-05	0.000408	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPIN1—obesity	2.28e-05	0.000405	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCF2—obesity	2.27e-05	0.000402	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CETP—obesity	2.25e-05	0.000399	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—obesity	2.24e-05	0.000398	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA5—obesity	2.23e-05	0.000396	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SDC1—obesity	2.22e-05	0.000395	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NAMPT—obesity	2.22e-05	0.000395	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GCK—obesity	2.21e-05	0.000392	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IAPP—obesity	2.2e-05	0.00039	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOC3—obesity	2.2e-05	0.00039	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKR1C3—obesity	2.19e-05	0.000388	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AGT—obesity	2.17e-05	0.000385	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SCARB1—obesity	2.15e-05	0.000382	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	2.14e-05	0.000381	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CLOCK—obesity	2.13e-05	0.000378	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC22A1—obesity	2.13e-05	0.000378	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—obesity	2.12e-05	0.000377	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.12e-05	0.000377	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SDC1—obesity	2.11e-05	0.000374	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—obesity	2.11e-05	0.000374	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—obesity	2.1e-05	0.000373	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—obesity	2.1e-05	0.000372	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SREBF1—obesity	2.09e-05	0.000371	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SULT2A1—obesity	2.08e-05	0.000368	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GLP1R—obesity	2.08e-05	0.000368	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKR1C3—obesity	2.07e-05	0.000368	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DPYD—obesity	2.04e-05	0.000363	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GOT2—obesity	2.03e-05	0.000361	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.01e-05	0.000356	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FASN—obesity	1.99e-05	0.000353	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BCHE—obesity	1.98e-05	0.000352	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PRKAR2B—obesity	1.97e-05	0.000349	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DCN—obesity	1.95e-05	0.000346	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GOT2—obesity	1.93e-05	0.000342	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.92e-05	0.00034	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2E1—obesity	1.91e-05	0.000339	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CPT1A—obesity	1.9e-05	0.000337	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NQO1—obesity	1.89e-05	0.000336	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FASN—obesity	1.89e-05	0.000335	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PARP1—obesity	1.88e-05	0.000333	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NAMPT—obesity	1.86e-05	0.000331	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.85e-05	0.000329	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—obesity	1.85e-05	0.000329	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LIPC—obesity	1.85e-05	0.000328	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCK—obesity	1.85e-05	0.000328	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOC3—obesity	1.84e-05	0.000326	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.83e-05	0.000326	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—obesity	1.83e-05	0.000324	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCG—obesity	1.81e-05	0.000322	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A4—obesity	1.81e-05	0.000322	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYCS—obesity	1.79e-05	0.000318	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CETP—obesity	1.78e-05	0.000317	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS1—obesity	1.77e-05	0.000314	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SDC1—obesity	1.76e-05	0.000313	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GOT1—obesity	1.76e-05	0.000312	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GGT1—obesity	1.76e-05	0.000312	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.75e-05	0.000311	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TCF7L2—obesity	1.75e-05	0.00031	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKR1C3—obesity	1.74e-05	0.000308	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NCOA1—obesity	1.73e-05	0.000307	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A4—obesity	1.72e-05	0.000305	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SCARB1—obesity	1.71e-05	0.000303	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP19A1—obesity	1.7e-05	0.000303	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—STK11—obesity	1.7e-05	0.000303	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.69e-05	0.000299	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—obesity	1.66e-05	0.000295	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GOT1—obesity	1.66e-05	0.000295	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SREBF1—obesity	1.66e-05	0.000295	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRL—obesity	1.64e-05	0.000291	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GOT2—obesity	1.61e-05	0.000287	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.59e-05	0.000283	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—COMT—obesity	1.58e-05	0.000281	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FASN—obesity	1.58e-05	0.00028	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BCHE—obesity	1.57e-05	0.000279	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARGC1A—obesity	1.56e-05	0.000277	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GNB3—obesity	1.56e-05	0.000277	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FOXO3—obesity	1.56e-05	0.000277	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMOX1—obesity	1.55e-05	0.000276	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GNAS—obesity	1.52e-05	0.00027	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2E1—obesity	1.52e-05	0.000269	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NQO1—obesity	1.5e-05	0.000266	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOB—obesity	1.49e-05	0.000264	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.47e-05	0.000261	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A4—obesity	1.44e-05	0.000255	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCG—obesity	1.44e-05	0.000255	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPL—obesity	1.42e-05	0.000252	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYCS—obesity	1.42e-05	0.000252	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOB—obesity	1.41e-05	0.000251	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GOT1—obesity	1.39e-05	0.000247	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GGT1—obesity	1.39e-05	0.000247	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX1—obesity	1.39e-05	0.000246	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NCOA1—obesity	1.37e-05	0.000244	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—STK11—obesity	1.35e-05	0.00024	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP19A1—obesity	1.35e-05	0.00024	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CD36—obesity	1.35e-05	0.00024	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LPL—obesity	1.35e-05	0.000239	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FOXO1—obesity	1.34e-05	0.000238	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—obesity	1.28e-05	0.000227	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—COMT—obesity	1.26e-05	0.000223	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARA—obesity	1.26e-05	0.000223	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRKCD—obesity	1.24e-05	0.000221	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GNB3—obesity	1.24e-05	0.00022	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARGC1A—obesity	1.24e-05	0.00022	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMOX1—obesity	1.23e-05	0.000219	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AGT—obesity	1.22e-05	0.000216	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—obesity	1.21e-05	0.000215	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GNAS—obesity	1.21e-05	0.000214	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOE—obesity	1.19e-05	0.000212	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOB—obesity	1.18e-05	0.00021	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAV1—obesity	1.18e-05	0.00021	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA1—obesity	1.18e-05	0.000209	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS2—obesity	1.15e-05	0.000205	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOE—obesity	1.13e-05	0.000201	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPL—obesity	1.13e-05	0.0002	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.13e-05	0.0002	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CAV1—obesity	1.12e-05	0.000199	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA1—obesity	1.12e-05	0.000198	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX1—obesity	1.1e-05	0.000196	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CG—obesity	1.08e-05	0.000191	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CD36—obesity	1.07e-05	0.00019	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BAD—obesity	1.05e-05	0.000187	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—obesity	1.04e-05	0.000184	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—POMC—obesity	1.02e-05	0.000182	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—INS—obesity	1.02e-05	0.000181	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—obesity	1.02e-05	0.00018	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS1—obesity	1.01e-05	0.000179	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARA—obesity	9.97e-06	0.000177	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AGT—obesity	9.66e-06	0.000171	CbGpPWpGaD
Nepafenac—PTGS2—Disease—INS—obesity	9.65e-06	0.000171	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOE—obesity	9.46e-06	0.000168	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CD—obesity	9.46e-06	0.000168	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAV1—obesity	9.38e-06	0.000166	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA1—obesity	9.35e-06	0.000166	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—obesity	9.34e-06	0.000166	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT2—obesity	9.33e-06	0.000166	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CD—obesity	8.96e-06	0.000159	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	8.96e-06	0.000159	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—obesity	8.93e-06	0.000159	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3R1—obesity	8.93e-06	0.000159	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—obesity	8.87e-06	0.000157	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TYK2—obesity	8.62e-06	0.000153	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RHOA—obesity	8.55e-06	0.000152	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CG—obesity	8.54e-06	0.000152	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3R1—obesity	8.46e-06	0.00015	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—obesity	8.46e-06	0.00015	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CB—obesity	8.24e-06	0.000146	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—obesity	8.24e-06	0.000146	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—obesity	8.17e-06	0.000145	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—POMC—obesity	8.13e-06	0.000144	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—INS—obesity	8.08e-06	0.000144	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CB—obesity	7.81e-06	0.000139	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTOR—obesity	7.81e-06	0.000139	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CD—obesity	7.51e-06	0.000133	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—obesity	7.41e-06	0.000132	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3R1—obesity	7.09e-06	0.000126	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—obesity	7.09e-06	0.000126	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CB—obesity	6.54e-06	0.000116	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT3—obesity	6.04e-06	0.000107	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MYC—obesity	5.61e-06	9.96e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—obesity	5.6e-06	9.94e-05	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CA—obesity	5.02e-06	8.92e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CA—obesity	4.76e-06	8.46e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—obesity	4.22e-06	7.49e-05	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—obesity	4.1e-06	7.29e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CA—obesity	3.99e-06	7.08e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—obesity	3.89e-06	6.91e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—obesity	3.26e-06	5.79e-05	CbGpPWpGaD
